Popular Articles From: EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity to Domino's Pizza® Launches Weeklong 50 Percent Off Pizza Deal on Cyber Monday


First New Medical Device Approved for Obesity in Over a Decade Novel Neuroscience-Based Technology Enables Safe, Durable Weight Loss Company to Host Conference Call Today at 12:00 PM ET ST.
Sign-up for EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity investment picks
Engility Holdings, Inc. (NYSE: EGL) today announced its receipt of notice from the Federal Trade Commission of the early termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) with respect to Engility’s proposed acquisition of TASC.
Sign-up for Engility Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of TASC investment picks
BOSTON and VANCOUVER, British Columbia, Dec.
Sign-up for EnerNOC Acquires Leading Customer Engagement Software Provider for Utilities investment picks
Ener-Core, Inc. (OTCQB:ENCR), whose proprietary Gradual Oxidation technology and equipment generates clean electric power from low quality and waste gases, announced the availability of a new company overview and question-and-answer (Q&A) video on its website.
Sign-up for Ener-Core Provides Shareholder Update Video investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs primarily in the infectious disease field, today announced the U.S. Food and Drug Administration (FDA) has approved AbbVie’s VIEKIRA PAK™ (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets) with or without ribavirin for the treatment of genotype 1 (GT1) patients with chronic hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Sign-up for Enanta Announces U.S. Food and Drug Administration Approves AbbVie’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C Virus investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs primarily in the infectious disease field, today announced that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted positive opinions for AbbVie’s investigational, all-oral, interferon-free treatment of VIEKIRAX™ (a combination of ombitasvir, paritaprevir (ABT-450) and ritonavir) plus EXVIERA™ (dasabuvir), with or without ribavirin (RBV), for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, and VIEKIRAX™ only, with RBV, for patients with genotype 4 (GT4) HCV infection.
Sign-up for Enanta Announces CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe investment picks
Emulex Corporation: WHAT: Emulex Corporation (NYSE:ELX) will present to investors attending the Needham Growth Conference on Tuesday, January 13, 2015 at 6:20 a.m. Pacific time.
Sign-up for Emulex to Present at 2015 Needham Growth Conference investment picks
OLD GREENWICH, Conn.
Sign-up for Ellington Residential Mortgage REIT Announces Dividend For The Fourth Quarter Of 2014 investment picks
Ellie Mae® (NYSE: ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced today that members of its management team will present at the Barclays Global Technology Conference at The Palace Hotel in San Francisco on Wednesday, December 10 th , 2014.
Sign-up for Ellie Mae to Present at the Barclays Global Technology Conference on December 10, 2014 investment picks
Revenues increase by 8% NORTHVALE, N.J., Nov.
Sign-up for Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015 investment picks
--Transactions transform Egalet into a commercial specialty pharmaceutical company paving the way for commercialization of late-stage pipeline of abuse-deterrent opioids -- --
Sign-up for Egalet Acquires/Licenses Two Innovative Approved Pain Products investment picks
Education Realty Trust, Inc. (“EdR”) (NYSE:EDR), one of the nation's largest developers, owners and managers of high-quality collegiate housing communities, today announced that its Board of Directors has approved a reverse stock split of EdR’s outstanding shares of common stock at a ratio of 1-for-3.
Sign-up for EdR Announces 1-for-3 Reverse Stock Split investment picks
Housing Market Still Grinding Upward WASHINGTON , Nov.
Sign-up for Economic Growth Slowing After Mid-Year Burst, but 2015 Growth Expected to Top 2014 investment picks
Eclipse Resources Corporation (“Eclipse Resources” or “the Company”) (NYSE: ECR) today announced financial and operational results for the quarter ended September 30, 2014.
Sign-up for Eclipse Resources Corporation Reports Third Quarter 2014 Results investment picks
Eclipse Resources Corporation (“Eclipse Resources” or “the Company”) (NYSE: ECR) today announced it will participate in the Wells Fargo Securities Energy Investment Symposium on December 10 th in New York City, and the Capital One Securities 9th Annual Energy Conference in New Orleans on December 11 th .
Sign-up for Eclipse Resources Corporation Announces Participation in Upcoming Conferences and Provides Operational Update investment picks
http://media.marketwire.com/attachments/201403/235782_White-Logo-Medium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164261&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Easton Pharmaceuticals Initiates Discussions With Canadian Medical Marijuana Association / Club investment picks
http://media.marketwire.com/attachments/201403/235782_White-Logo-Medium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158625&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Easton Pharmaceuticals Engages Accredited Independent Auditor to Commence an Audit of Company's Financial Statements for Years Ending 2013 and 2014 investment picks
E*TRADE Financial Corporation (NASDAQ:ETFC) today announced that it will present at the Goldman Sachs U.S. Financial Services Conference.
Sign-up for E*TRADE Financial Corporation Announces Upcoming Speaking Engagement investment picks
Dynegy Inc. (NYSE:DYN), through its wholly-owned subsidiaries, Dynegy Finance I, Inc. (the Duke Escrow Issuer) and Dynegy Finance II, Inc. (the EquiPower Escrow Issuer), has closed into escrow: The gross proceeds from the offerings, less initial purchasers’ discounts and expenses, have been placed into escrow pending the consummation of Dynegy’s previously announced acquisitions of ownership interests in certain Midwest generation assets from Duke Energy Corporation (the Duke Midwest Assets Acquisition) and EquiPower Resources Corp and Brayton Point Holdings, LLC from Energy Capital Partners (the EquiPower Acquisition). Upon consummation of the acquisitions and certain other conditions, Dynegy intends to use the net proceeds from the offerings to pay a portion of the cash consideration in the Duke Midwest Assets Acquisition and the EquiPower Acquisition and to pay
Sign-up for Dynegy Closes $5.1 Billion Senior Unsecured Notes Offerings investment picks
CHICAGO , Dec.
Sign-up for Duff & Phelps Closed-End Funds Announce Dividends investment picks
http://media.marketwire.com/attachments/201301/55947_dryships.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1162123&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for DryShips Inc. Announces Repayment of 5% Convertible Notes Due 2014 investment picks
http://media.marketwire.com/attachments/201301/55947_dryships.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154941&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for DryShips Inc. Announces Closing of Offering of 250,000,000 Shares of Common Stock investment picks
Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) today announced a distribution of $0.0625 per share of common stock, payable on January 2, 2015 to shareholders of record at the close of business on December 16, 2014.
Sign-up for Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) Announces Dividend investment picks
The Dow Chemical Company (NYSE: DOW) announced today that its Board of Directors has declared a 14 percent increase in the Company’s dividend, from $0.37 per share to $0.42 per share in the fourth quarter.
Sign-up for Dow Board of Directors Declares 14 Percent Dividend Increase; Announces New $5 Billion Tranche to Share Repurchase Program, Bringing Total to $9.5 Billion investment picks
Dan Kramer Named Executive Vice President of Client Service Delivery NEW YORK , Jan.
Sign-up for Douglas Shulman Appointed Senior Executive Vice President and Global Head of Client Service Delivery at BNY Mellon investment picks
Offer available for pizza orders placed through Domino's digital ordering channels ANN ARBOR, Mich.
Sign-up for Domino's Pizza® Launches Weeklong 50 Percent Off Pizza Deal on Cyber Monday investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity to Domino's Pizza® Launches Weeklong 50 Percent Off Pizza Deal on Cyber Monday
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent